The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

Systemic mastocytosis is a complex disease defined by abnormal growth and accumulation of neoplastic mast cells in various organs. Most patients exhibit a D816V-mutated variant of KIT, which confers resistance against imatinib. Clinical problems in systemic mastocytosis arise from mediator-related s...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneeweiss, Mathias, Peter, Barbara, Bibi, Siham, Eisenwort, Gregor, Smiljkovic, Dubravka, Blatt, Katharina, Jawhar, Mohamad, Berger, Daniela, Stefanzl, Gabriele, Herndlhofer, Susanne, Greiner, Georg, Hoermann, Gregor, Hadzijusufovic, Emir, Gleixner, Karoline V., Bettelheim, Peter, Geissler, Klaus, Sperr, Wolfgang R., Reiter, Andreas, Arock, Michel, Valent, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927976/
https://www.ncbi.nlm.nih.gov/pubmed/29439183
http://dx.doi.org/10.3324/haematol.2017.179895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927976/
https://www.ncbi.nlm.nih.gov/pubmed/29439183
http://dx.doi.org/10.3324/haematol.2017.179895

Ejemplares similares